Search results

I don't know that it is even yet out of clinical trials. If it is, it would very likely be Rx only.

I don't know that it is even yet out of clinical trials. If it is, it would very likely be Rx only.

I don't know that it is even yet out of clinical trials. If it is, it would very likely be Rx only.

I don't know that it is even yet out of clinical trials. If it is, it would very likely be Rx only.

During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...

During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...

During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...

During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...

During clinical trials, there were no reports of hearing loss from inhaled Tobi, there have been some post-market reports, but at least some of those patients were also receiving IV therapy. It seems that there is significantly less risk of ototoxicity with inhaled tobramycin. Those who have...

Well, Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...

Well, Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...

Well, Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...

Well, Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy issues). More...

Well, <br /> <br />Genetics is a complex topic. For a while we have understood that sometimes being heterozygous dominant (genotype) does not completely mask the phenotypic expression of the recessive gene. That is, some carriers demonstrated CF like symptoms (gastric problems, sinus/allergy...

I'm around to chat sometimes. Jonathan, 28 from Pa. AIM=DevinMichael575

I'm around to chat sometimes. Jonathan, 28 from Pa. AIM=DevinMichael575

I'm around to chat sometimes. Jonathan, 28 from Pa. AIM=DevinMichael575

I'm around to chat sometimes. Jonathan, 28 from Pa. AIM=DevinMichael575

I'm around to chat sometimes. Jonathan, 28 from Pa. AIM=DevinMichael575

I think oral abx would suffice. They can always given him IV abx during his procedure when he's going to have to have a peripheral line anyway.